Tag

Rsv

All articles tagged with #rsv

March Vaccine Checklist for Those Over 50
health3 days ago

March Vaccine Checklist for Those Over 50

Doctors urge people over 50 to get up to date on vaccines this March, as aging immune systems raise the risk of serious illness from flu, COVID-19, RSV, and shingles. Key vaccines to consider include the influenza shot, updated COVID boosters, RSV (especially for those 50–74 at risk or over 75), shingles (zoster), pneumococcal, and Td/Tdap boosters; some may also need MMR and varicella based on risk. Vaccines are widely available at primary care clinics, pharmacies, and local health departments, and getting them can reduce hospitalizations and long-term complications. In addition to vaccines, a healthy lifestyle and planning for fall vaccinations are advised.

Last-Call Winter Vaccines: Flu Shot and Boosters Before February Ends
health1 month ago

Last-Call Winter Vaccines: Flu Shot and Boosters Before February Ends

With flu, COVID-19, RSV and other viruses circulating together, doctors urge getting key vaccines now. The flu vaccine is recommended through February, and boosters for COVID-19, a TDaP booster, and vaccines for RSV and pneumococcus are advised for eligible groups, especially adults over 65. Vaccination reduces risk of severe illness, hospitalization and community spread, even if you still contract some viruses. Vaccines are widely available at doctor’s offices, pharmacies and health departments, and immunity takes about two weeks to develop. February isn’t too late to get protected and help ease winter healthcare strain.

Flu uptick returns as RSV and COVID activity remains elevated in parts of the U.S.
health1 month ago

Flu uptick returns as RSV and COVID activity remains elevated in parts of the U.S.

CDC reports that after a three‑week decline, flu activity is rising across the U.S. while RSV and COVID-19 remain elevated in various states (13 states with higher flu, 21 with RSV, 11 with COVID growth). Overall acute respiratory illness is still low to moderate, but infants face the highest RSV hospitalizations and ED visits. There have been eight additional pediatric flu deaths this season (52 total), and flu hospitalizations have reached about 15,080. Influenza A(H3N2) remains dominant with subclade K mutations that may help it evade vaccine immunity. Vaccination remains encouraged and not too late, though uptake is low; wastewater data show high levels of COVID-19, flu, and RSV in several states.

AAP Vaccine Guidance Gains Ground as CDC Schedule Faces Pushback
health1 month ago

AAP Vaccine Guidance Gains Ground as CDC Schedule Faces Pushback

The American Academy of Pediatrics released updated childhood vaccination guidelines, including a RSV vaccine, and many doctors and an increasing number of states are following the AAP guidance over the CDC’s revised schedule. Officials say the science is the same, but the policy shift—with about 28 states reportedly deviating from federal guidance by Jan 20—signals a major change in public health strategy and trust dynamics, as clinicians emphasize following established pediatric recommendations and informing families.

Geisinger Hospitals Hit Record Capacity as Virus Surge Strains Care System
health1 month ago

Geisinger Hospitals Hit Record Capacity as Virus Surge Strains Care System

Geisinger’s Lackawanna and Luzerne counties hospitals are operating above 100% capacity amid a surge in respiratory viruses (influenza, RSV and COVID-19) and more patients choosing Geisinger as Commonwealth Health faces uncertainty; officials urge patients to seek appropriate care—primary care, telehealth, or urgent care—rather than defaulting to emergency departments for mild to moderate symptoms—to help relieve strain and ensure timely care for those with serious conditions.

RSV vaccines prove effective as US tightens access restrictions
health-policy1 month ago

RSV vaccines prove effective as US tightens access restrictions

New data reinforce that RSV vaccines dramatically reduce hospitalizations, with pregnancy-based protection around 70% and newborn monoclonal antibodies about 81%, and four JAMA studies confirm declines. Despite this, the administration’s restrictions to high‑risk infants could raise RSV hospitalizations and complicate vaccine logistics in a fragmented US system. Safety reviews are underway after trial deaths, though officials say there’s no proven vaccine link, and many countries rely on universal prenatal vaccination.